Endymed
Endymed Ltd provides energy based medical aesthetic treatment systems for the professional and consumer markets in North America, Europe, the Middle East, Africa, Asia, Oceania, Latin America, and internationally. The company offers ENDYMED PRO, an all-in-one treatment platform; ENDYMED PURE 2.0, a compact and flexible treatment platform; Pure Laser, a laser hair removal system; Intensif, a RF mi… Read more
Endymed (ENDY) - Total Assets
Latest total assets as of September 2024: ILA18.21 Million ILA
Based on the latest financial reports, Endymed (ENDY) holds total assets worth ILA18.21 Million ILA as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Endymed - Total Assets Trend (2008–2023)
This chart illustrates how Endymed’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Endymed - Asset Composition Analysis
Current Asset Composition (December 2023)
Endymed's total assets of ILA18.21 Million consist of 83.7% current assets and 16.3% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 47.5% |
| Accounts Receivable | ILA1.23 Million | 6.0% |
| Inventory | ILA5.44 Million | 26.6% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA131.00K | 0.6% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2008–2023)
This chart illustrates how Endymed's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Endymed's current assets represent 83.7% of total assets in 2023, an increase from 72.4% in 2008.
- Cash Position: Cash and equivalents constituted 47.5% of total assets in 2023, up from 25.6% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 27.0% in 2008.
- Asset Diversification: The largest asset category is inventory at 26.6% of total assets.
Endymed Competitors by Total Assets
Key competitors of Endymed based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Endymed - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Endymed generates 1.11x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Endymed generates $ 2.70 in net profit.
Endymed - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.05 | 4.19 | 3.07 |
| Quick Ratio | 2.58 | 2.92 | 2.34 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA11.38 Million | ILA 13.18 Million | ILA 7.64 Million |
Endymed - Advanced Valuation Insights
This section examines the relationship between Endymed's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.94 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 4.0% |
| Total Assets | ILA20.49 Million |
| Market Capitalization | $118.10K USD |
Valuation Analysis
Below Book Valuation: The market values Endymed's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Endymed's assets grew by 4.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Endymed (2008–2023)
The table below shows the annual total assets of Endymed from 2008 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | ILA20.49 Million | +4.02% |
| 2022-12-31 | ILA19.70 Million | +0.52% |
| 2021-12-31 | ILA19.60 Million | +44.61% |
| 2020-12-31 | ILA13.55 Million | -3.85% |
| 2019-12-31 | ILA14.09 Million | +19.97% |
| 2018-12-31 | ILA11.75 Million | +33.44% |
| 2017-12-31 | ILA8.80 Million | -15.22% |
| 2016-12-31 | ILA10.38 Million | -10.93% |
| 2015-12-31 | ILA11.66 Million | -77.50% |
| 2014-12-31 | ILA51.82 Million | +145.81% |
| 2013-12-31 | ILA21.08 Million | -0.83% |
| 2012-12-31 | ILA21.26 Million | +67.67% |
| 2011-12-31 | ILA12.68 Million | -40.92% |
| 2010-12-31 | ILA21.46 Million | +69.42% |
| 2009-12-31 | ILA12.67 Million | -43.10% |
| 2008-12-31 | ILA22.26 Million | -- |